Carbidopa/levodopa - Wikipedia, the free encyclopedia
The combination of carbidopa and levodopa is used to treat Parkinson's disease and Dopa-Responsive Dystonia (DRD). It is sold under several brand names, ...
http://en.wikipedia.org/wiki/Carbidopa/levodopa...
|
Levodopa and Carbidopa: MedlinePlus Drug Information
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601068.htm...
|
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4 ...
Several controlled-release carbidopa/levodopa preparations have been formulated to achieve a more stable and extended antiparkinsonian action. ...
http://www.ncbi.nlm.nih.gov/pubmed/2685650...
|
Carbidopa-Levodopa–Induced Recrudescence of Premorbid Tic Disorder ...
Sir: Dopamine agonists, such as carbidopa-levodopa, have utility in alleviating symptoms of movement disorders, e.g., parkinsonism, and can reduce ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...
|
Carbidopa/levodopa for smoking cessation: a pilot study with ...
A pilot open-label study using carbidopa/levodopa for smokers wanting to stop smoking was carried out at the Mayo Clinic Nicotine Research Center, ...
http://www.ncbi.nlm.nih.gov/pubmed/11072443...
|
SINEMET® CR (CARBIDOPA-LEVODOPA) SUSTAINED-RELEASE TABLETS
SINEMET* CR (Carbidopa-Levodopa) is a sustained-release combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. ...
http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cf...
|
Immediate-release and controlled-release carbidopa/levodopa in PD ...
CONCLUSION: Despite the progressive nature of PD, both the immediate-release and sustained-release carbidopa/levodopa formulations maintained a similar ...
http://www.ncbi.nlm.nih.gov/pubmed/10496260...
|
Sinemet (carbidopa/levodopa) Tablets December 2008
10 Jul 2009 ... Sinemet (carbidopa/levodopa) Tablets December 2008. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Reducing dosing frequency of carbidopa/levodopa: double-blind ...
OBJECTIVE: We compared IPX054, a bilayer tablet of immediate- and extended- release carbidopa/levodopa (CD/LD) given twice daily to standard CD/LD given 4
...
http://www.ncbi.nlm.nih.gov/pubmed/19620848...
|
The effect of low dose carbidopa/levodopa on prolactin and growth ...
1 Low doses of carbidopa/levodopa (12.5 mg 1-alpha-methyl-dopahydrazine, 125 mg levodopa) were administered orally to 29 patients with tumours of the breast ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...
|
